NCT01087671已完成3 期
Ocular Signs and Symptoms in Patients With Ocular Hypertension or Open-angle Glaucoma Switched From Preserved Latanoprost 0.005% Eye Drops to Preservative Free Tafluprost Eye Drops
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Santen Oy
- 入组人数
- 185
- 主要终点
- Assessment of changes in ocular symptoms and signs
研究概览
简要总结
The purpose of this study is to investigate if changes in ocular signs and symptoms occur in patients with ocular hypertension or glaucoma when they switch from latanoprost 0.005% (Xalatan) to preservative free Tafluprost eye drops.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with a diagnosis of ocular hypertension or open angle glaucoma for which the patient has been using latanoprost 0.005% as his/her prior medication.
- •Evaluable patients must have ocular surface related symptoms and/or signs with their prior medication.
排除标准
- 未提供
研究组 & 干预措施
Open-lable study with one arm
Other
干预措施: tafluprost (Drug)
结局指标
主要结局
Assessment of changes in ocular symptoms and signs
时间窗: From Screening (Visit 1) to12 weeks.
Ocular symptoms include: irritation/burning/stinging, foreign body sensation, tearing, itching and dry eye sensation. Following signs will be evaluated: tear break-up time, corneal and conjunctival fluorescein staining, blepharitis, conjunctival redness and tear secretion (schirmer test).
次要结局
- Secondary outcome measures include the assessment of safety and quality of life parameters.(From Screening (visit 1) to 12 weeks)
研究者
相似试验
已完成
3 期
Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye DropsOcular HypertensionOpen-Angle GlaucomaNCT00596791Santen Oy150
已完成
4 期
Corneal and Conjunctival Sensitivity and Staining StudyMyopiaHyperopiaNCT00455455University of Waterloo50
尚未招募
不适用
A study to measure pressure changes in eye while a person undergoes surgery for spine fracture lying on his back during surgeryCTRI/2019/01/017211Department of Anaesthesiology
已完成
不适用
Comparison of Ocular Surface Features in Patients With Diabetes and Dry Eye SyndromeDiabetes Mellitus Type 2Dry Eye SyndromeNCT03576300Peking University Third Hospital120
尚未招募
不适用
Ophthalmic manifestations andcorrelation with serum levels of VEGF-D in COVID-19 recovered subjectsCTRI/2021/09/036975ARCHANA T R
